Bulletin
Investor Alert

New York Markets Close in:

VBI Vaccines Inc.

NAS: VBIV

GO
/marketstate/country/us

Market open

 --Real time quotes

Aug 12, 2020, 12:06 p.m.

/zigman2/quotes/201705917/composite

$

3.39

Change

-0.26 -7.12%

Volume

Volume 4.26m

Real time quotes

/zigman2/quotes/201705917/composite

Previous close

$ 3.65

$ 3.39

Change

-0.26 -7.12%

Day low

Day high

$3.35

$3.84

Open

52 week low

52 week high

$0.47

$6.93

Open

Annual Financials for VBI Vaccines Inc.

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 955,000548,000865,0003.36M2.22M
Cost of Goods Sold (COGS) incl. D&A 4.62M3.67M5.19M4.51M9.11M
COGS excluding D&A 3.48M3.07M4.46M3.97M7.9M
Depreciation & Amortization Expense 1.14M606,000730,000542,0001.2M
Depreciation 1.14M540,000667,000481,0001.14M
Amortization of Intangibles -66,00063,00061,00062,000
Gross Income (3.66M)(3.12M)(4.33M)(1.15M)(6.89M)
20152016201720182019 5-year trend
SG&A Expense 7.3M21.73M32.95M58.98M39.22M
Research & Development 618,0009.97M20.92M38.47M26.33M
Other SG&A 6.68M11.76M12.03M20.51M12.89M
Other Operating Expense -----
Unusual Expense 1.35M--278,0006.29M
EBIT after Unusual Expense (12.32M)--(60.41M)(52.4M)
Non Operating Income/Expense -189,000736,000(560,000)(218,000)
Non-Operating Interest Income 44,000--622,000835,000
Equity in Affiliates (Pretax) -----
Interest Expense 2.61M324,0002.88M3.25M3.03M
Gross Interest Expense 2.61M324,0002.88M3.25M3.03M
Interest Capitalized -----
Pretax Income (14.88M)(24.99M)(39.43M)(63.6M)(54.81M)
Income Tax (129,000)(1.78M)(431,000)--
Income Tax - Current Domestic --(3,000)--
Income Tax - Current Foreign -5,000---
Income Tax - Deferred Domestic -(1.79M)(428,000)--
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (14.76M)(23.21M)(39M)(63.6M)(54.81M)
Minority Interest Expense -----
Net Income (14.76M)(23.21M)(39M)(63.6M)(54.81M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (14.76M)(23.21M)(39M)(63.6M)(54.81M)
Preferred Dividends -----
Net Income Available to Common (14.76M)(23.21M)(39M)(63.6M)(54.81M)
EPS (Basic) -(0.77)(0.88)(0.97)(0.46)
Basic Shares Outstanding -30.04M44.16M65.65M119.45M
EPS (Diluted) -(0.77)(0.88)(0.97)(0.46)
Diluted Shares Outstanding -30.04M44.16M65.65M119.45M
EBITDA (9.82M)(24.24M)(36.55M)(59.59M)(44.9M)
Link to MarketWatch's Slice.